abstract |
The present invention relates to various novel Hydantoin derivative compounds and compositions for inhibiting P2X 7 receptor activity comprising them as an active ingredient. The present invention can be usefully used for the prevention or treatment of various diseases related to the activity of the P2X 7 receptor, that is, chronic inflammatory disease, inflammatory pain, neuropathic pain, autoimmune disease or degenerative disease. |